Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Does the Medical Doctor's Pension Fund diagnose multiple sclerosis correct?].
Sonic Hedgehog Signaling Is a Positive Oligodendrocyte Regulator during Demyelination.
[The metabolic abnormalities in plaques of multiple sclerosis patients - the assessment in proton MR spectroscopy (1HMRS)].
The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas.
Olfactory dysfunction in patients with neuromyelitis optica.
Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data.
Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
Does the six-minute walk test measure walking performance or physical fitness in persons with multiple sclerosis?
AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities.
Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation.
Comprehensive Profile of Cardiopulmonary Exercise Testing in Ambulatory Persons with Multiple Sclerosis.
The Roles of Vitamin D and Its Analogs in Inflammatory Diseases.
Nationwide Incidence of Acquired Central Nervous System Demyelination in Icelandic Children.
Discovering Gene Regulatory Elements Using Coverage-based Heuristics.
Use of Cannabinoids for Spasticity and Pain Management in MS.
Expression of DNA methylation genes in secondary progressive multiple sclerosis.
The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases.
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.
Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach.
Quality of life in patients with multiple sclerosis in Republic of Srpska.
The perceptions of people with multiple sclerosis about the NHS provision of physiotherapy services.
Mediation of Protection and Recovery From Experimental Autoimmune Encephalomyelitis by Macrophages Expressing the Human Voltage-Gated Sodium Channel NaV1.5.
Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.
Combined central and peripheral demyelination: A case description.
Pages
« first
‹ previous
…
520
521
522
523
524
525
526
527
528
…
next ›
last »